^
    13d
    Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas (clinicaltrials.gov)
    P2, N=2, Terminated, National Cancer Institute (NCI) | Completed --> Terminated; This protocol was terminated prematurely because the prior principal investigator departed the Institute without treating any participants.
    Trial termination
    |
    BRCA (Breast cancer early onset) • CD4 (CD4 Molecule)
    |
    BRCA mutation
    |
    Trodelvy (sacituzumab govitecan-hziy) • Mycapssa (octreotide) • loperamide • octreotide acetate solution for injection